Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer
Clinical trial NCT02994576 · COMPLETED
Trial details
- NCT number
- NCT02994576
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-12
- Primary completion
- 2023-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.